SYSMEX CORP.UNSP.ADR 1/2 (0YX0) - Net Assets
Based on the latest financial reports, SYSMEX CORP.UNSP.ADR 1/2 (0YX0) has net assets worth €483.16 Billion EUR (≈ $564.86 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€669.41 Billion ≈ $782.61 Billion USD) and total liabilities (€186.25 Billion ≈ $217.75 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See SYSMEX CORP.UNSP.ADR 1/2 balance sheet quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €483.16 Billion |
| % of Total Assets | 72.18% |
| Annual Growth Rate | 9.99% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.91 |
SYSMEX CORP.UNSP.ADR 1/2 - Net Assets Trend (2022–2025)
This chart illustrates how SYSMEX CORP.UNSP.ADR 1/2's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of SYSMEX CORP.UNSP.ADR 1/2.
Annual Net Assets for SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
The table below shows the annual net assets of SYSMEX CORP.UNSP.ADR 1/2 from 2022 to 2025. Also explore how fast is SYSMEX CORP.UNSP.ADR 1/2 growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €464.53 Billion ≈ $543.09 Billion |
+7.31% |
| 2024-03-31 | €432.90 Billion ≈ $506.10 Billion |
+11.47% |
| 2023-03-31 | €388.36 Billion ≈ $454.03 Billion |
+11.26% |
| 2022-03-31 | €349.05 Billion ≈ $408.08 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SYSMEX CORP.UNSP.ADR 1/2's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 31.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €402.82 Billion | 86.86% |
| Other Components | €60.96 Billion | 13.14% |
| Total Equity | €463.78 Billion | 100.00% |
SYSMEX CORP.UNSP.ADR 1/2 Competitors by Market Cap
The table below lists competitors of SYSMEX CORP.UNSP.ADR 1/2 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
United Internet AG NA
XETRA:UTDI
|
$4.70 Billion |
|
Tamarack Valley Energy Ltd
TO:TVE
|
$4.70 Billion |
|
AUTO1 Group SE
F:AG1
|
$4.71 Billion |
|
Temenos Group AG
SW:TEMN
|
$4.71 Billion |
|
Castech Inc
SHE:002222
|
$4.70 Billion |
|
Torex Gold Resources Inc
TO:TXG
|
$4.70 Billion |
|
Xian Sunresin New Materials Co Ltd
SHE:300487
|
$4.70 Billion |
|
Synnex Technology International Corp
TW:2347
|
$4.69 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SYSMEX CORP.UNSP.ADR 1/2's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 432,045,000,000 to 463,776,000,000, a change of 31,731,000,000 (7.3%).
- Net income of 53,669,000,000 contributed positively to equity growth.
- Dividend payments of 18,081,000,000 reduced retained earnings.
- Share repurchases of 2,000,000 reduced equity.
- New share issuances of 248,000,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €53.67 Billion | +11.57% |
| Dividends Paid | €18.08 Billion | -3.9% |
| Share Repurchases | €2.00 Million | -0.0% |
| Share Issuances | €248.00 Million | +0.05% |
| Other Changes | €-4.10 Billion | -0.88% |
| Total Change | €- | 7.34% |
Book Value vs Market Value Analysis
This analysis compares SYSMEX CORP.UNSP.ADR 1/2's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | €554.95 | €6.45 | x |
| 2023-03-31 | €617.56 | €6.45 | x |
| 2024-03-31 | €692.94 | €6.45 | x |
| 2025-03-31 | €743.71 | €6.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SYSMEX CORP.UNSP.ADR 1/2 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.57%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.55%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 1.43x
- Recent ROE (11.57%) is below the historical average (11.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 12.66% | 12.12% | 0.75x | 1.39x | €9.26 Billion |
| 2023 | 11.81% | 11.15% | 0.77x | 1.37x | €7.02 Billion |
| 2024 | 11.49% | 10.76% | 0.75x | 1.43x | €6.43 Billion |
| 2025 | 11.57% | 10.55% | 0.76x | 1.43x | €7.29 Billion |
Industry Comparison
This section compares SYSMEX CORP.UNSP.ADR 1/2's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $8,537,866,184
- Average return on equity (ROE) among peers: -10.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SYSMEX CORP.UNSP.ADR 1/2 (0YX0) | €483.16 Billion | 12.66% | 0.39x | $4.70 Billion |
| LEPU MED.T.B. SP.GDR O.N. (07Z0) | $17.76 Billion | 5.42% | 0.47x | $160.91K |
| BIORETEC OY (0TN) | $8.23 Million | -46.03% | 0.29x | $16.10 Million |
| INMODE LTD IS -01 (154) | $554.62 Million | 29.12% | 0.16x | $711.77 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $27.01 Million |
| Medtronic PLC (2M6) | $53.23 Billion | 5.03% | 1.00x | $83.04 Billion |
| Peijia Medical Limited (4WO) | $2.27 Billion | -17.26% | 0.17x | $401.71 Million |
| AVITA Medical Inc (51KB) | $84.74 Million | -31.47% | 0.16x | $172.49 Million |
| BRAINCOOL AB (5YL) | $175.80 Million | -21.08% | 0.09x | $18.88 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.75 Billion | -16.50% | 0.09x | $107.57 Million |
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more